Diagnovus Closes Seed Financing Round

Diagnovus, LLC, a Nashville, Tennessee-based newly formed molecular diagnostics company, has closed a seed financing round of undisclosed amount.

Founding investors are Limestone Fund and TriStar Technology Ventures.

Diagnovus, which targets rare forms of cancer, including pediatric cancers, plans to identify, in-license, develop and commercialize diagnostic assays that have been developed at leading institutions around the United States.

Diagnovus’ first full-time employee will be James Stover, Ph.D., who is leaving his position as Vice President of Tennessee Technology Development Corporation and will join as Vice President of Business Development.


Join the discussion